(*) USA Approval Date: 2021. 06.07>
(*) USA Approval Year: 2018.
>MAb Inj. for IV Use
Company
Generic Name: RavulizuMAb-cwvz
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 7
Patent>UpDate: 2022. 06.28
RTM
RTM Web-Site